EVIVIOS MED | OUR HISTORY
THE EVOLUTION
OF A SCIENTIFIC
IDEA
From medically supervised weight
management to a comprehensive
metabolic health system.
The Beginning of a New Approach
Eurodiet Med develops an innovative weight management method based on medical supervision and exclusive collaboration with physicians.
Medical Research and International Recognition
Participation in scientific studies, conducted in collaboration with the Diabetes Center of Tzaneio Hospital and the First Department of Propaedeutic Internal Medicine at Laiko General Hospital, strengthens the scientific foundation of the Method.
In 2011, research findings are presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon.
Knowledge Beyond Borders
The company's operations expand to Cyprus and Romania.
In 2014, more than 20,000 people receive information and undergo health screenings as part of a nationwide awareness campaign conducted through a specially equipped mobile unit. In 2017, a further awareness campaign takes place across the Greek islands, focusing on type 2 diabetes.
In 2018, the specialized Diaverse and Diaverse Plus protocols are developed to support the management and potential remission of type 2 diabetes.
In 2019, recognizing the crucial role of air quality in human health, Evivios Med establishes an exclusive partnership with an international company specializing in air purification and disinfection systems, broadening its approach to prevention and well-being.
Health, Responsibility and Response
During the pandemic, the company launches health-focused initiatives, including Immune Boost and the donation of 30 air purification systems to hospitals treating COVID-19 patients.
In 2021, the company participates in a scientific study at Attikon University Hospital involving patients with severe obesity and psoriasis, continuing its commitment to research.
The Transformation into the New Evivios Med
The company enters a new era with its rebranding as Evivios Med, the scientific advancement of its Method under medical and scientific guidance, and the development of strategic partnerships with multinational nutrition companies.
Technological advancement becomes a central focus, with upgraded digital systems, the adoption of modern applications, and the development of new tools for service and support.
In 2024, the Evivios® trademark is registered across all 27 European Union member states, while the company strengthens its scientific education initiatives, participation in medical conferences, and digital presence.
In 2025, Evivios Med expands its international presence into Croatia. At the same time, it develops collaborations with physicians and dietitians, alongside enhanced public communication and awareness initiatives focused on metabolic health.
In addition, new branded packaging and private-labeling activities are developed.
A Comprehensive Metabolic Health System
Evivios Med continues to refine its processes and tools, to continuously improve the quality of its services and enhancing the value it delivers to collaborating physicians and the people who benefit from them.
The company has held ISO 9001 and ISO 14001 certifications since 2022, and ISO 22000 certification since 2025, reflecting its commitment to systematic quality management, environmental responsibility, and food safety.
A JOURNEY WITH MEASURABLE IMPACT
450+Collaborating Physicians
20,000+People Reached and Screened
27EU Member States Where Evivios® Is Registered
70+Medical Conference Participations and Speaking Engagements